Balyasny Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1M | Buy |
+1,221,610
| New | +$16.1M | 0.02% | 569 |
|
|
2025
Q1 | – | Sell |
-175,428
| Closed | -$2.94M | – | 2072 |
|
|
2024
Q4 | $2.94M | Sell |
175,428
-505,993
| -74% | -$8.48M | ﹤0.01% | 999 |
|
|
2024
Q3 | $10.9M | Sell |
681,421
-341,701
| -33% | -$5.46M | 0.02% | 639 |
|
|
2024
Q2 | $9.24M | Buy |
1,023,122
+768,676
| +302% | +$6.94M | 0.02% | 663 |
|
|
2024
Q1 | $2.88M | Buy |
+254,446
| New | +$2.88M | 0.01% | 1001 |
|